| Takeda Pharma AG - Xagrid 0,5 mg, Hartkapseln | | 54720 | | 01 | | Xagrid 0,5 mg | | Hartkapseln | | L01XX35 | | Anagrelide | | 08.12.1999 | | |
| | Composition | | anagrelidum 0.5 mg ut anagrelidi hydrochloridum monohydricum, povidonum K 30, lactosum 65.76 mg, lactosum monohydricum 53.74 mg, cellulosum microcristallinum, crospovidonum, magnesii stearas, Kapselhülle: gelatina, E 171, Drucktinte: lacca, propylenglycolum, ammoniae solutio concentrata, kalii hydroxidum, E 172 (nigrum), pro capsula. | | Packungsbestandteile | | Capsules | | | | | Principe actif | Concentr. |
|---|
| Anagrelide | 0.5 mg |
| | BAG: Principe actif | Concentr. |
|---|
| Anagrelide | 0.5 mg |
| | | | Agents auxilliaires | Concentr. | informations additionels |
|---|
| (Nigrum) | | | | Ammoniae Solutio Concentrata | | | | Cellulosum Microcristallinum | | | | Crospovidonum | | | | E 171 | | color. | | E 172 | | color. | | Gelatina | | Kapselhülle | | Kalii Hydroxidum | | | | Lacca | | Drucktinte | | Lactosum | 65.76 mg | | | Lactose Monohydrate | 53.74 mg | | | Magnesii Stearas | | | | Povidonum K | 30 | | | Pro Capsula | | | | Propylenglycol | | |
| |
| | numéro d'emballage | Taille des présentations | PEF | PP | Cat. | LS | Hors commerce (MedRef) |
|---|
| 068 | 100 Gélule(s) | 207.67 | 240.45 | B | LS | Oui |
|
|
